PA2024 is a fusion of prostatic acid phosphatase (PAP), an immunogenic prostate-specific antigen elevated in PCa, with GM-CSF (granulocyte macrophage colony-stimulating factor). The gene discussed is ACP3; the disease is posterior cortical atrophy.